MAM
PCRX icon

MPM Asset Management’s Pacira BioSciences PCRX Stock Holding History

MPM Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-39,025
Closed -$3.58M – 14
2014
Q2 		$3.58M Hold
39,025
– – 1.21% 10
2014
Q1 		$2.73M Sell
39,025
-60,975
-61% -$4.15M 1.16% 9
2013
Q4 		$5.75M Sell
100,000
-724,255
-88% -$38.1M 1.86% 9
2013
Q3 		$39.6M Hold
824,255
– – 11.17% 4
2013
Q2 		$23.9M Buy
+824,255
New +$23.8M 10.58% 4

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marsico Capital Management
Marsico Capital Management Denver, Colorado $3.83B AUM 63.68% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Investors US
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MPM Asset Management's PCRX Position: Q3 2014 in Review

MPM Asset Management sold out of Pacira BioSciences (PCRX) in Q3 2014, closing a stake of 39,025 shares — an estimated $3.58M sold.

MPM Asset Management first reported a position in PCRX in Q2 2013 and held it in 5 quarters. The position peaked at $39.6M in Q3 2013. 208 funds tracked by Wall St. Rank hold PCRX as of Q3 2014.

  • MPM Asset Management reported no remaining Pacira BioSciences position as of Q3 2014 after selling out during the quarter.
  • MPM Asset Management sold 39,025 Pacira BioSciences shares in Q3 2014, an estimated $3.58M.
  • MPM Asset Management first reported a position in Pacira BioSciences in Q2 2013 and held it in 5 quarters.
  • MPM Asset Management's Pacira BioSciences position peaked at $39.6M in Q3 2013.
  • 208 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2014.

Based on MPM Asset Management's 13F filing for Q3 2014, filed 23 Oct 2014.